netbook
desktop
mobile
tablet-landscape
tablet
phone-landscape
phone
Research to Prevent Blindness

Alternative Treatment for Diabetic Retinopathy

A clinical trial funded by the National Institutes of Health has found that the drug ranibizumab (Lucentis) is highly effective in treating proliferative diabetic retinopathy (PDR), a complication of diabetes that damages blood vessels in the light-sensitive retina in the back of the eye. Lucentis is used to treat wet macular degeneration as well as diabetic macula edema. The study found the treatment no less effective than the laser therapy which currently is the standard treatment for PDR.

Read the press release.

Read the study.

In a RPB-supported commentary, Timothy W. Olsen, MD, notes that "this important study [...] represents a major step forward for patients with PDR by providing the ophthalmologists who manage their retinal disease with new options." But he adds a cautionary note. 

Read the commentary.

 

Related News: Diabetic Retinopathy, Top Story

Four RPB-supported researchers and a Scientific Advisory Panel member have been honored with the prestigious 2018 António Champalimaud Vision Award for their groundbreaking research

Four RPB-supported researchers and a Scientific Advisory Panel member have been honored with the prestigious 2018 António Champalimaud Vision Award for their groundbreaking research

Read More

 

IN THE FUTURE, ALZHEIMER’S MAY BE PREDICTED DURING EYE EXAMS

RPB-funded researchers at Washington University School of Medicine in St. Louis (WUSTL) have found a correlation in 30 older patients between retina thinning and elevated levels of tau and amyloid proteins that are the hallmark of Alzheimer’s disease.

Read More

 

Research to Prevent Blindness and Association of University Professors of Ophthalmology Announce 2018 Recipient of RPB David F. Weeks Award for Outstanding AMD Research

RPB and AUPO announce 2018 recipient of David F. Weeks Award for outstanding AMD research.

Read More

 

Groundbreaking Gene Therapy for Retinal Disease

The first patient receives an FDA-approved gene therapy for inherited retinal disease at Mass. Eye and Ear.

Read More

 

RPB and AAO Award Grants for Big Data Research to Advance Patient Care

Award recipients to use IRIS Registry database to conduct population-based studies.

Read More

 

Research to Prevent Blindness Expands Grants Program

Many of the organization’s individual grants will now be open to researchers at any U.S. academic medical center.

Read More

 

Subscribe

Get our email updates filled with the latest news from our researchers about preventing vision loss, treating eye disease and even restoring sight. Unsubscribe at any time. Under our privacy policy, we'll never share your contact information with a third party.